The Increasing Incidence of Pet Ownership in the World Is Boosting the Growth of the Global Veterinary Dermatology Drugs Market
Veterinary Dermatology Drugs Market
Veterinary Dermatology Drugs Market, By Type of Drug (Antibiotics, Antifungal drugs, Anti-inflammatory drugs, Immunotherapy drugs, Parasiticides, Others), By Animal Type (Dogs, Cats, Horses, Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030.
Market Overview:
Veterinary
dermatology drugs refer to pharmaceutical products specifically formulated for
the treatment and management of skin conditions and diseases in animals. These
drugs are designed to address a wide range of dermatological disorders in
various animal species, including dogs, cats, horses, and livestock. Veterinary
dermatology drugs may come in different forms such as topical creams, ointments,
sprays, shampoos, oral medications, and injectables.
Competitive Landscape:
Major
players operating in the global
veterinary dermatology drugs market include IDEXX Laboratories, Inc.,
Kindred Biosciences, Inc., Ceva Sante Animale, Bayer AG, Dechra Pharmaceuticals
PLC., Vetoquinol S.A., Virbac, Boehringer Ingelheim International GmbH, Elanco
Animal Health Incorporated, and Zoetis Inc.
Key Market Drivers:
The
rising trend of pet ownership, coupled with the increasing humanization of
pets, has led to higher demand for veterinary dermatology drugs. Pet owners are
increasingly seeking effective treatments for their pets' skin-related
conditions, driving the demand for dermatology drugs. This is expected to
augment the growth of the global veterinary dermatology drugs market. For
instance, according to Forbes, in 2020, there were around 88.9 million pet dogs
in the world.
There
is an increasing focus on animal health and well-being, leading to greater
awareness and proactive measures to address dermatological issues in animals.
This has resulted in higher veterinary visits and the need for appropriate
dermatology treatments.
Dermatological
disorders, such as allergies, skin infections, parasitic infestations, and
autoimmune diseases, are becoming more common in animals. The need to diagnose
and treat these conditions is estimated to enhance the growth of the global
veterinary dermatology drugs market.
Advancements
in veterinary medicine have led to the development of innovative and more
effective dermatology drugs. This includes the introduction of targeted
therapies, improved formulations, and enhanced treatment protocols, driving the
market growth.
Covid-19 Impact Analysis:
The
COVID-19 pandemic led to disruptions in veterinary services, with reduced
clinic visits and limited access to veterinary care for routine and
non-emergency cases. This temporarily affected the overall demand for
veterinary dermatology drugs. This restrained the growth of the global
veterinary dermatology drugs market.
Key Takeaways:
·
North America is
expected to dominate the growth of the global
veterinary dermatology drugs market, owing to the large pet-owning
population, increased awareness of animal health, and advancements in
veterinary medicine. The United States, in particular, represents a major
market for veterinary dermatology drugs. For instance, according to Forbes,
around 66% of United States households own a pet.
·
Europe is
estimated to witness high growth in the global veterinary dermatology drugs
market, with countries like the United Kingdom, Germany, and France witnessing
a high prevalence of dermatological conditions in animals. For instance, in
2020, Dechra and MediBaeacon partnered in order to develop an advanced
non-invasive diagnostic tool for assessing skin issues in pets.
Comments
Post a Comment